Vesalius Biocapital Partners

About The Fund

Vesalius Biocapital Partners is a venture capital firm based in Strassen, Luxembourg, that specializes in providing venture capital to young European innovative life science companies. Since their inception in 2007, they have established a significant presence in the life science sector with more than 150 million under management across two funds. They actively invest in early-stage companies that are involved in the human health industry, including therapeutic, medical device, diagnostic, and biotechnology sectors. With a history of contributing to the development of 20 companies, their approach is hands-on, playing the role of lead investor in a large majority of financing rounds. Vesalius Biocapital Partners focuses on companies based in Europe, facilitating easy interaction with the company management. Their investment strategy is comprehensive and adaptable to all stages of company development, with a particular interest in relatively early-stage projects that boast of sound proprietary technology, robust intellectual property, unique team skills, and a clear competitive edge supported by solid data. The three key investment areas they target include therapeutics, medical devices, and diagnostics, recognizing the potential for innovation and growth within these sectors. They offer more than just capital, as they guide and support companies throughout their growth journey, playing an instrumental role in the evolving European life sciences landscape.